ARDELYX, INC. Cost of Revenue
ARDELYX, INC. (ARDX) reported Cost of Revenue of $1.54 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2023-05-03
- ARDELYX, INC. cost of revenue for the quarter ending 2023-03-31 was $1.54M, a 1708.24% increase year-over-year.
- ARDELYX, INC. cost of revenue for the quarter ending 2022-12-31 was $3.16M.
- ARDELYX, INC. cost of revenue for the quarter ending 2022-09-30 was $732.00K.
- ARDELYX, INC. cost of revenue for the quarter ending 2022-06-30 was $138.00K.
- ARDELYX, INC. cost of revenue for fiscal 2022 was $4.12M, a 311.70% increase from fiscal 2021.
- ARDELYX, INC. cost of revenue for fiscal 2021 was $1.00M, a 589.66% increase from fiscal 2020.
- ARDELYX, INC. cost of revenue for fiscal 2020 was $145.00K, a 75.83% decline from fiscal 2019.
- ARDELYX, INC. cost of revenue for fiscal 2019 was $600.00K, a 28.76% increase from fiscal 2018.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2023-03-31 | $1.54M 10-Q · filed 2023-05-03 | $4.70M derived: sum of 2 quarters · filed 2023-05-03 | $5.43M derived: sum of 3 quarters · filed 2023-05-03 | $5.57M derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $3.89M derived: sum of 2 quarters · filed 2023-03-02 | $4.03M derived: sum of 3 quarters · filed 2023-03-02 | $4.12M 10-K · filed 2023-03-02 |
| 2022-09-30 | $732.00K 10-Q · filed 2022-11-03 | $870.00K derived: sum of 2 quarters · filed 2022-11-03 | $955.00K 10-Q · filed 2022-11-03 | $955.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-06-30 | $138.00K 10-Q · filed 2022-08-04 | $223.00K 10-Q · filed 2022-08-04 | $223.00K derived: sum of 3 quarters · filed 2023-05-03 | $223.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-03-31 | $85.00K 10-Q · filed 2023-05-03 | $85.00K derived: sum of 2 quarters · filed 2023-05-03 | $85.00K derived: sum of 3 quarters · filed 2023-05-03 | $85.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $1.00M 10-K · filed 2023-03-02 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $1.00M 10-Q · filed 2022-11-03 | $1.00M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $1.00M 10-Q · filed 2022-08-04 | $1.00M derived: sum of 3 quarters · filed 2023-03-02 | $1.00M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $1.00M 10-Q · filed 2022-05-05 | $1.00M derived: sum of 2 quarters · filed 2023-03-02 | $1.00M derived: sum of 3 quarters · filed 2023-03-02 | $1.15M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $4.00K derived: sum of 2 quarters · filed 2023-03-02 | $145.00K derived: sum of 3 quarters · filed 2023-03-02 | $145.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $141.00K derived: sum of 2 quarters · filed 2021-11-12 | $141.00K 10-Q · filed 2021-11-12 | $141.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $141.00K 10-Q · filed 2021-08-13 | $141.00K 10-Q · filed 2021-08-13 | $141.00K derived: sum of 3 quarters · filed 2022-02-28 | $741.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $600.00K derived: sum of 3 quarters · filed 2022-02-28 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $600.00K derived: sum of 2 quarters · filed 2022-02-28 | $600.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | $600.00K 10-Q · filed 2020-11-05 | $600.00K 10-Q · filed 2020-11-05 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $2.00K derived: sum of 2 quarters · filed 2021-03-08 | $2.00K derived: sum of 3 quarters · filed 2021-03-08 | $466.00K 10-K · filed 2021-03-08 |
| 2018-09-30 | $2.00K 10-Q · filed 2019-11-06 | $2.00K derived: sum of 2 quarters · filed 2019-11-06 | $466.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $464.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $464.00K 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $8.40M 10-K · filed 2020-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |